Skip to main content

Klein Matthew B.

In the past year, 10 open-market sale filings worth $4.41M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$4.41M
10 filings
Net
−$4.41M
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Klein Matthew B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTCT PTC Therapeutics, Inc.

CHIEF EXECUTIVE OFFICER23 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 11, 2022 (view filing)Jan 74 daysKlein Matthew B.Chief Operating OfficerSSale−775$38.53−$29.9K−4.5%16.5K after
Apr 21, 2022 (view filing)Apr 192 daysKlein Matthew B.CHIEF OPERATING OFFICERSSale−897$42.52−$38.1K−1.6%56.6K after
Jan 11, 2023 (view filing)Jan 92 daysKlein Matthew B.CHIEF OPERATING OFFICERSSale−731$41.66−$30.5K−0.9%82.4K after
Jan 12, 2023 (view filing)Jan 10-112 daysKlein Matthew B.CHIEF OPERATING OFFICERSSale−4.52K$43.64−$197.1K−5.5%77.9K after2 lots
Apr 20, 2023 (view filing)Apr 182 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−1.21K$52.04−$63.0K−1.2%102.6K after10b5-1
Jan 9, 2024 (view filing)Jan 54 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−10.1K$27.15−$274.4K−5.7%168.2K after10b5-1
Jan 10, 2024 (view filing)Jan 8-92 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−7.68K$28.90−$222.0K−4.6%160.5K after2 lots10b5-1
Apr 19, 2024 (view filing)Apr 172 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−1.31K$25.14−$32.9K−0.6%229.2K after10b5-1
Apr 22, 2024 (view filing)Apr 193 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−3.36K$24.89−$83.7K−1.5%225.8K after10b5-1
Jan 3, 2025 (view filing)Dec 31, 20243 daysKlein Matthew B.CHIEF EXECUTIVE OFFICERSSale−8.28K$45.16−$373.9K−3.7%217.5K after10b5-1

See all 23 trades at PTCT

CLPT ClearPoint Neuro, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 26, 2026 (view filing)May 215 daysKlein Matthew B.DirectorSSale−16.0K$11.59−$185.4K−25.4%46.9K after